Hybrid imaging is the future of molecular imaging

Biomedical Imaging and Intervention Journal

Volumn 3, Issue 3, 2007, Pages

  Hicks, Rodney J ^a   Lau, E W F ^a   Binns, D S ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

FDG; Hybrid imaging; Oncology; PET; SPECT; Tomography

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HEALTH CARE AVAILABILITY; HISTORY OF MEDICINE; HYBRID IMAGING; IMAGE ANALYSIS; MAGNETIC FIELD; MEDICAL INSTRUMENTATION; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MEDICINE; PATIENT POSITIONING; POSITRON EMISSION TOMOGRAPHY; RISK BENEFIT ANALYSIS;

EID: 57049123863     PISSN: None     EISSN: 18235530     Source Type: Journal    
DOI: 10.2349/biij.3.3.e49     Document Type: Article

References (62)

1. Blahd WH. Ben Cassen and the development of the rectilinear scanner. Semin Nucl Med 1996; 26(3):165-70.
2. Rizzo G, Gilardi MC, Prinster A et al. A bioimaging integration system implemented for neurological applications. J Nucl Biol Med 1994; 38(4):579-85.
3. Pietrzyk U, Herholz K, Schuster A et al. Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI. Eur J Radiol 1996; 21(3):174-82.
4. Kramer EL, Noz ME, Sanger JJ et al. CT-SPECT fusion to correlate radiolabeled monoclonal antibody uptake with abdominal CT findings. Radiology 1989; 172(3):861-5.
5. Koral KF, Zasadny KR, Kessler ML et al. CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J Nucl Med 1994; 35(10):1714-20.
6. Wahl RL, Quint LE, Cieslak RD et al. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993; 34(7):1190-7.
7. Kraus GE, Bernstein TW, Satter M et al. A technique utilizing positron emission tomography and magnetic resonance/computed tomography image fusion to aid in surgical navigation and tumor volume determination. J Image Guid Surg 1995; 1(6):300-7.
8. Vansteenkiste JF, Stroobants SG, Dupont PJ et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998; 25(11):1495-501.
9. Cai J, Chu JC, Recine D et al. CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method. Int J Radiat Oncol Biol Phys 1999; 43(4):883-91.
10. Delbeke D, Sandler MP. The role of hybrid cameras in oncology. Semin Nucl Med 2000; 30(4):268-80.
11. Israel O, Keidar Z, Iosilevsky G et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med 2001; 31(3):191-205.
12. Beyer T, Townsend DW, Brun T et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41(8):1369-79.
13. Beyer T, Townsend DW. Putting 'clear' into nuclear medicine: a decade of PET/CT development. Eur J Nucl Med Mol Imaging 2006; 33(8):857-61.
14. Muehllehner G, Karp JS. Positron emission tomography. Phys Med Biol 2006; 51(13):R117-37.
15. Surti S, Kuhn A, Werner ME et al. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 2007; 48(3):471-80.
16. O'Connor MK, Kemp BJ. Single-photon emission computed tomography/ computed tomography: basic instrumentation and innovations. Semin Nucl Med 2006; 36(4):258-66.
17. Wu TH, Huang YH, Lee JJ et al. Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner. Eur J Nucl Med Mol Imaging 2004; 31(1):38-43.
18. Seemann MD. Whole-body PET/MRI: the future in oncological imaging. Technol Cancer Res Treat 2005; 4(5):577-82.
19. Hayakawa N, Uemura K, Ishiwala K et al. A PET-MRI registration technique for PET studies of the rat brain. Nucl Med Biol 2000; 27(2):121-5.
20. Borgwardt L, Hojgaard L, Carstensen H et al. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) 'uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. J Clin Oncol 2005; 23(13):3030-7.
21. Seemann MD, Meisetschlaeger G, Gaa J et al. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 2006; 11(2):58-65.
22. Ruf J, Lopez Hanninen E, Bohmig M et al. Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer. Pancreatology 2006; 6(6):512-9.
23. Marsden PK, Strut D, Keevil SF et al. Simultaneous PET and NMR. Br J Radiol 2002; 75 Spec No:S53-9.
24. Pichler BJ, Judenhofer MS, Catana C et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med 2006; 47(4):639-47.
25. Lucignani G. Time-of-flight PET and PET/MRI: recurrent dreams or actual realities? Eur J Nucl Med Mol Imaging 2006; 33(8):969-71.
26. Catana C, Wu Y, Judenhofer MS et al. Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J Nucl Med 2006; 47(12):1968-76.
27. Meguro K, LeMestric C, Landeau B et al. Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study. J Neurol Neurosurg Psychiatry 2001; 71(3):315-21.
28. Utriainen M, Komu M, Vuorinen V et al. Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 2003; 62(3):329-38.
29. Kwock L, Smith JK, Castillo M et al. Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. Lancet Oncol 2006; 7(10):859-68.
30. Gaa J, Rummeny EJ, Seemann MD. Whole-body imaging with PET/MRI. Eur J Med Res 2004; 9(6):309-12.
31. Hany TF, Steinert HC, Goerres GW et al. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002; 225(2):575 -81.
32. Antoch G, Stattaus J, Nemat AT et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229(2):526-33.
33. Bar-Shalom R, Yefremov N, Guralnik L et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44(8):1200-9.
34. Bristow RE, del Carmen MG, Pannu HK et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 2003; 90(3):519-28.
35. Cohade C, Osman M, Marshall LN et al. PET-CT: accuracy of PET and CT spatial registration of lung lesions. Eur J Nucl Med Mol Imaging 2003; 30(5):721-6.
36. Kantorova I, Lipska L, Belohlavek O et al. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.
37. Cerfolio RJ, Ojha B, Bryant AS et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004; 78(3):1017-23; discussion 1017-23.
38. Even-Sapir E, Parag Y, Lerman H et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004; 232(3):815-22.
39. Grisaru D, Almog B, Levine C et al. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies. Gynecol Oncol 2004; 94(3):680-4.
40. Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004; 45 Suppl 1:82S-95S.
41. Chen YK, Su CT, Ding HJ et al. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Res 2006; 26(2B):1471-7.
42. De Wever W, Ceyssens S, Mortelmans L et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 2007; 17(1):23-32.
43. Sebastian S, Lee SI, Horowitz NS et al. PET-CT vs. CT alone in ovarian cancer recurrence. Abdom Imaging 2007.
44. Shin SS, Jeong YY, Min JJ et al. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging 2007.
45. Lau WF, Binns DS, Ware RE et al. Clinical experience with the first combined positron emission tomography/computed tomography scanner in Australia. Med J Aust 2005; 182(4):172-6.
46. Mirzaei S, Guerchaft M, Bonnier C et al. Use of segmented CT transmission map to avoid metal artifacts in PET images by a PET-CT device. BMC Nucl Med 2005; 5(1):3.
47. Meikle SR, Bailey DL, Hooper PK et al. Simultaneous emission and transmission measurements for attenuation correction in whole-body PET. J Nucl Med 1995; 36(9):1680-8.
48. Kamel E, Hany TF, Burger C et al. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002; 29(3):346-50.
49. Nakamoto Y, Osman M, Cohade C et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med 2002; 43(9):1137-43.
50. Goerres GW, Burger C, Kamel E et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003; 226(3):906-10.
51. Ter-Pogossian MM, Bergmann SR, Sobel BE. Influence of cardiac and respiratory motion on tomographic reconstructions of the heart: implications for quantitative nuclear cardiology. J Comput Assist Tomogr 1982; 6(6):1148-55.
52. Osman MM, Cohade C, Nakamoto Y et al. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 2003; 44(2):240-3.
53. Nehmeh SA, Erdi YE, Pan T et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 2004; 31(12):3179-86.
54. Hicks RJ, Mac Manus MP. 18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact? J Nucl Med 2003; 44(1):30-2.
55. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med 2007; 48 Suppl 1:78S-88S.
56. Schillaci O, Danieli R, Manni C et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 2004; 25(7):705-10.
57. Horger M, Eschmann SM, Pfannenberg C et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR Am J Roentgenol 2004; 183(3):655-61.
58. Hillel PG, van Beek EJ, Taylor C et al. The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol 2006; 61(7):579-87.
59. Roach PJ, Schembri GP, Ho Shon LA et al. SPECT/CT imaging using a spiral CT scanner for anatomical localization: Impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun 2006; 27(12):977-87.
60. Sodee DB, Sodee AE, Bakale G. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med 2007; 37(1):17-28.
61. Schillaci O, Danieli R, Filippi L et al. Scintimammography with a hybrid SPECT/CT imaging system. Anticancer Res 2007; 27(1B):557-62.
62. Hielscher AH, Bluestone AY, Abdoulaev GS et al. Near-infrared diffuse optical tomography. Dis Markers 2002; 18(5-6):313-37.